Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date (Ascending) Package Discontinuation Date Status
00069-0342-01 00069-0342 Bevacizumab-bvzr Zirabev 400.0 mg/16mL Immunotherapy Monoclonal Antibody VEGFR Intravenous Jan. 13, 2020 In Use
72485-0216-08 72485-0216 Docetaxel Docetaxel 160.0 mg/8mL Chemotherapy Antimitotic Agent Taxane Intravenous Jan. 15, 2020 In Use
72485-0215-04 72485-0215 Docetaxel Docetaxel 80.0 mg/4mL Chemotherapy Antimitotic Agent Taxane Intravenous Jan. 15, 2020 In Use
72485-0214-01 72485-0214 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jan. 15, 2020 In Use
72485-0221-02 72485-0221 Gemcitabine Hydrochloride Gemcitabine 200.0 mg/5.26mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jan. 15, 2020 In Use
72485-0222-10 72485-0222 GEMCITABINE HYDROCHLORIDE Gemcitabine 1.0 g/26.3mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jan. 15, 2020 In Use
72485-0223-20 72485-0223 Gemcitabine Hydrochloride Gemcitabine 2.0 g/52.6mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jan. 15, 2020 In Use
16714-0120-01 16714-0120 Fosaprepitant Fosaprepitant 150.0 mg/5mL Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Intravenous Jan. 16, 2020 In Use
42658-0021-01 42658-0021 Daunorubicin hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan. 20, 2020 In Use
42658-0019-01 42658-0019 Daunorubicin hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan. 20, 2020 In Use

Found 10,000 results in 8 millisecondsExport these results